Crossref
Drug repurposing of some US FDA-approved drugs using Binding strength Studies for the Treatment of Methicillin-resistant Staphylococcus aureus Infection
Journal of PhytoPharmaceutical and Advanced Chemistry · 2026-04 · 1 (1) · 30-44
DOI: 10.66220/ecsrwe33 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of PhytoPharmaceutical and Advanced Chemistry, 2026-04. Verfasst von Dibakar Roy.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Roy, D. (2026). Drug repurposing of some US FDA-approved drugs using Binding strength Studies for the Treatment of Methicillin-resistant Staphylococcus aureus Infection. Journal of PhytoPharmaceutical and Advanced Chemistry, 1(1), 30-44. https://doi.org/10.66220/ecsrwe33
Vancouver
Roy D. Drug repurposing of some US FDA-approved drugs using Binding strength Studies for the Treatment of Methicillin-resistant Staphylococcus aureus Infection. Journal of PhytoPharmaceutical and Advanced Chemistry. 2026;1(1):30-44. doi:10.66220/ecsrwe33
BibTeX
@article{Roy2026,
author = {Roy, Dibakar},
title = {Drug repurposing of some US FDA-approved drugs using Binding strength Studies for the Treatment of Methicillin-resistant Staphylococcus aureus Infection},
journal = {Journal of PhytoPharmaceutical and Advanced Chemistry},
year = {2026},
volume = {1},
number = {1},
pages = {30--44},
doi = {10.66220/ecsrwe33}
}
EUVIMED